Development of a Commercial Manufacturing Process for Sotorasib, a First-in-Class KRASG12C Inhibitor

被引：18

作者：

Zhang, Liang ^{[1
]}

Griffin, Daniel J. ^{[1
]}

Beaver, Matthew G. ^{[1
]}

Blue, Laura E. ^{[1
,2
]}

Borths, Christopher J. ^{[1
]}

Brown, Derek B. ^{[1
]}

Caille, Seb ^{[2
]}

Chen, Ying ^{[2
]}

Cherney, Alan H.

Cochran, Brian M. ^{[2
]}

Colyer, John T. ^{[2
]}

Corbett, Michael T. ^{[2
]}

Correll, Tiffany L. ^{[1
]}

Crockett, Richard D. ^{[2
]}

Dai, Xi-Jie ^{[1
]}

Dornan, Peter K. ^{[1
]}

Farrell, Robert P. ^{[2
]}

Hedley, Simon J. ^{[2
]}

Hsieh, Hsiao-Wu ^{[1
]}

Huang, Liang ^{[2
]}

Huggins, Seth ^{[2
]}

Liu, Min ^{[2
]}

Lovette, Michael A. ^{[2
]}

Quasdorf, Kyle ^{[2
]}

Powazinik, William

Reifman, Jonathan ^{[2
]}

Robinson, Jo Anna ^{[2
]}

Sangodkar, Rahul P. ^{[1
]}

Sharma, Sonika ^{[1
]}

Kumar, Srividya Sharvan ^{[1
]}

Smith, Austin G. ^{[2
]}

St-Pierre, Gabrielle ^{[2
]}

Tedrow, Jason S. ^{[2
]}

Thiel, Oliver R. ^{[1
]}

Truong, Jonathan V. ^{[1
]}

Walker, Shawn D. ^{[1
]}

Wei, Carolyn S.

Wilsily, Ashraf

Xie, Yong ^{[1
]}

Yang, Ning ^{[1
]}

Parsons, Andrew T. ^{[1
]}

机构：

[1] Amgen Inc, Pivotal & Commercial Synthet, Cambridge, MA 02142 USA

[2] Amgen Inc, Prepivotal Attribute Sci, Thousand Oaks, CA 91320 USA

来源：

ORGANIC PROCESS RESEARCH & DEVELOPMENT | 2022年 / 26卷 / 11期

关键词：

atropisomerism; axial chirality; acrylamide; KRAS; Suzuki-Miyaura; POCl3; chlorination; BOC; palladium; cross-coupling; covalent inhibitor; catalysis; AMG; 510;

D O I：

10.1021/acs.oprd.2c00249

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

A commercial process to manufacture sotorasib (AMG 510), a first-in-class KRASG12C inhibitor, is described. Development efforts focused on rendering a fit-for-purpose early-phase route into a viable long-term commercial process through the reduction of side reactions to improve yield and product quality, as well as reducing cycle times of crystallization processes by improving particle properties and filtration times. These improvements were key to ensuring clinical supply and commercial launch. The final route consists of five synthetic operations from starting material M-1, including a telescoped two-step sequence, and a final form

引用

页码：3115 / 3125

页数：11

共 14 条

[1] Hydrolysis of Phosphoryl Trichloride (POCl3): Characterization, in Situ Detection, and Safe Quenching of Energetic Metastable Intermediates
Achmatowicz, Michal M.
Thiel, Oliver R.
Colyer, John T.
Hu, Jack
Elipe, Maria Victoria Silva
Tomaskevitch, Joe
Tedrow, Jason S.
Larsen, Robert D.
[J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2010, 14 (06) : 1498 - 1508
[2] Armarego WLF, 2009, PURIFICATION OF LABORATORY CHEMICALS, 6TH EDITION, P88, DOI 10.1016/B978-1-85617-567-8.50012-3
[3] Batra M., 2022, REGULATORY RAPPORTEU, V19, P32
[4] Byrne FP., 2016, SUSTAINABLE CHEM PRO, V4, P1, DOI [10.1186/s40508-016-0051-z, DOI 10.1186/S40508-016-0051-Z]
[5] Base-Catalyzed Aryl-B(OH)2 Protodeboronation Revisited: From Concerted Proton Transfer to Liberation of a Transient Aryl Anion
Cox, Paul A.
Reid, Marc
Leach, Andrew G.
Campbell, Andrew D.
King, Edward J.
Lloyd-Jones, Guy C.
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2017, 139 (37) : 13156 - 13165
[6] Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors
Lanman, Brian A.
Allen, Jennifer R.
Allen, John G.
Amegadzie, Albert K.
Ashton, Kate S.
Booker, Shon K.
Chen, Jian Jeffrey
Chen, Ning
Frohn, Michael J.
Goodman, Guy
Kopecky, David J.
Liu, Longbin
Lopez, Patricia
Low, Jonathan D.
Ma, Vu
Minatti, Ana E.
Nguyen, Thomas T.
Nishimura, Nobuko
Pickrell, Alexander J.
Reed, Anthony B.
Shin, Youngsook
Siegmund, Aaron C.
Tamayo, Nuria A.
Tegley, Christopher M.
Walton, Mary C.
Wang, Hui-Ling
Wurz, Ryan P.
Xue, May
Yang, Kevin C.
Achanta, Pragathi
Bartberger, Michael D.
Canon, Jude
Hollis, L. Steven
McCarter, John D.
Mohr, Christopher
Rex, Karen
Saiki, Anne Y.
San Miguel, Tisha
Volak, Laurie P.
Wang, Kevin H.
Whittington, Douglas A.
Zech, Stephan G.
Lipford, J. Russell
Cee, Victor J.
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (01) : 52 - 65
[7] Selection of boron reagents for Suzuki-Miyaura coupling
Lennox, Alastair J. J.
Lloyd-Jones, Guy C.
[J]. CHEMICAL SOCIETY REVIEWS, 2014, 43 (01) : 412 - 443
[8] Organotrifluoroborate Hydrolysis: Boronic Acid Release Mechanism and an Acid-Base Paradox in Cross-Coupling
Lennox, Alastair J. J.
Lloyd-Jones, Guy C.
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2012, 134 (17) : 7431 - 7441
[9] Large-Scale Applications of Transition Metal-Catalyzed Couplings for the Synthesis of Pharmaceuticals
Magano, Javier
Dunetz, Joshua R.
[J]. CHEMICAL REVIEWS, 2011, 111 (03) : 2177 - 2250
[10] Parsons A. T., 2020, Improved Synthesis of Key Intermediate of KRAS G12C Inhibitor Compound, Patent No. [WO2020102730A1, 2020102730]

← 1 2 →